Battle of Will for the Bard's soul 1
Shakespeare's work should be appreciated as complex art as well as marketable entertainment, says Kate McLuskie. Whereas Tom McAlindon believes that theory-driven radicals are sapping the joy from...
Shakespeare's work should be appreciated as complex art as well as marketable entertainment, says Kate McLuskie. Whereas Tom McAlindon believes that theory-driven radicals are sapping the joy from...
Shakespeare's work should be appreciated as complex art as well as marketable entertainment, says Kate McLuskie. Whereas Tom McAlindon believes that theory-driven radicals are sapping the joy from...
London, 21 December 2004 A Strategic Framework for Hydrogen Energy in the UK - final report (full version) (PDF, 3,894kB) Index, executive summary and chapter 1 (PDF, 306kB) Chapters 2-7 (PDF, 1,...
Brussels, 21 Dec 2004 19 out of the 25 Environment Ministers who met in Brussels on 20 December voted against approval of the GT73 oilseed rape, genetically modified (GM) by Monsanto in order to...
17 December 2004 at detection thresholdIn its December plenary session the EESC adopted two opinions concerning genetically modified crops and the European action plan for organic food and farming....
Brussels, 21 Dec 2004 The Council noted that no qualified majority was attained to allow for a decision on the Commission's proposal authorising the placing on the market of a oilseed rape product (...
Brussels, 21 Dec 2004 A Network of Excellence on innovative production machines and systems (I*PROMS) is addressing what it sees as the six 'manufacturing challenges for 2020'. The network will...
Brussels, 21 Dec 2004 The European Commission has published synopses of a selection of ERA-NET projects receiving funding under the Sixth Framework Programme (FP6). The brochure is the second in a...
Brussels, 21 Dec 2004 An international conference entitled 'Evolution of the life sciences' will be held in Edinburgh, UK, from 23 to 25 February. As well as addressing the usual areas of uncertainty...
Washington, 20 December 2004 Divestitures Required in the U.S. Market for Solid Organ Transplant Acute Therapy Drugs In the Matter of Genzyme Corporation and Ilex Oncology, Inc., FTC File No. 041...
This is the last Daily News update for 2004; the service will resume on Monday, January 10. The Times Higher sends all our readers best wishes for the holiday season and new year. Exeter...
Brussels, 20 Dec 2004 The results of an online survey on 'a European strategy for nanotechnology' illustrate the areas that Europe's researchers consider should be a priority. Respondents...
Brussels, 20 Dec 2004 France will increase its funding for nanosciences and nanotechnologies from 30 million to 70 million euro over three years, the country's Research Minister, François d'Aubert,...
Brussels, 20 Dec 2004 The discovery of Mars' watery past by NASA's Spirit and Opportunity rovers has been chosen as the key scientific advance of 2004 in an annual list compiled by Science magazine...
Brussels, 20 Dec 2004 Europe's leading marine research funding organisations are set to increase their joint activities following the launch of a three million euro ERA-NET scheme funded by the...